We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

February 21, 2018

Tung v. Bristol-Myers Squibb Company et al

Track this case

Case Number:



New York Southern

Nature of Suit:


Multi Party Litigation:

Class Action


J. Paul Oetken


Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. September 11, 2018

    Bristol-Myers Looks To Ax Investor Suit Over Clinical Trial

    Bristol-Myers Squibb asked a New York federal judge on Tuesday to toss a proposed class action alleging it misled investors about the clinical trial patients for its new lung cancer drug, saying the investors have yet to show a material misstatement or omission made by the company.


To view the parties, register now.